This review systematically synthesizes recent research data on the HGF/c-Met pathway and elucidates its disease-related mechanisms: it promotes malignant tumor progression, participates in viral infectious disease pathogenesis, facilitates tissue injury repair, and is implicated in diabetes mellitus and Alzheimer's disease. This evidence concerns the gene MET and early-onset autosomal dominant Alzheimer disease.